| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/26/2003 | WO2003051358A1 Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 06/26/2003 | WO2003051304A2 Bioadhesive drug delivery system with enhanced gastric retention |
| 06/26/2003 | WO2003051289A2 Solubilized topoisomerase poison agents |
| 06/26/2003 | WO2003051277A2 Novel compounds |
| 06/26/2003 | WO2003051274A2 Benzodiazepine derivatives, preparation thereof and use thereof |
| 06/26/2003 | WO2003040109A3 Quinazoline derivatives as antitumor agents |
| 06/26/2003 | WO2003020005A3 Lp mammalian proteins; related reagents |
| 06/26/2003 | WO2002094202A3 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
| 06/26/2003 | WO2002048390A3 Methods and kits for detecting protein kinases |
| 06/26/2003 | WO2002047611A8 Cddo-compounds and combination therapies thereof |
| 06/26/2003 | WO2002046385A3 Enzymes |
| 06/26/2003 | WO2002032378A9 Fusion cells and cytokine compositions for treatment of disease |
| 06/26/2003 | WO2002018608A3 Methods for enhancing the efficacy of cancer therapy |
| 06/26/2003 | WO2002016597A3 Lipid metabolism enzymes |
| 06/26/2003 | WO2001090154A3 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 06/26/2003 | US20030121065 Polyfunctional base sequence and artificial gene containing the same |
| 06/26/2003 | US20030120096 Reacting racemic beta-lactam with lithium- 7-protected baccatin III- complex to form 3'desphenyl-3'-(1-napthyl)taxol; antitumor agents |
| 06/26/2003 | US20030120093 Reacting cytotoxic hydrofuranoxanthones with palladium complex and benzoquinone in presence of dimethyl sulfoxide; antiproliferative/antitumor agents; topoisomerase inhibitors; downregulating oncogenes |
| 06/26/2003 | US20030120071 Chemical compounds |
| 06/26/2003 | US20030120069 1,1'-((Propane-1,3-diyl)dioxy)bis((11aS)-7-methoxy-2 -methy lidene-1,2,3,11-tetrahydro-5H-pyrrolo(2,1-c)(1,4)benzodiazep in-5-one) derivatives; viricides, parasiticide, bactericides, gene therapy and treating cisplatin refractory disease |
| 06/26/2003 | US20030120059 Cell surface molecule-induced macrophage activation |
| 06/26/2003 | US20030120045 Immobilization onto polyoxyethylene glycol |
| 06/26/2003 | US20030119914 Bis(thio-hydrazide amide) compounds; anticancer agents |
| 06/26/2003 | US20030119895 Anticancer agents |
| 06/26/2003 | US20030119894 Methods for treatment of cancer or neoplastic disease and for inhibiting growth of cancer cells and neoplastic cells |
| 06/26/2003 | US20030119878 A 1-arylalkyl-3-aminoalkyl-1,4-dihydropyrid-4-one derivative; sexual disorders; anticarcinogenic agents; benign prostatic hypertrophy/fibroids of the uterus; endometriosis, polycystic ovarian disease, precocious puberty; contraceptives |
| 06/26/2003 | US20030119877 Pyridine derivatives useful as cyclooxygenase inhibitor |
| 06/26/2003 | US20030119876 Compounds for the treatment of protozoal diseases |
| 06/26/2003 | US20030119864 Farnesyl transferase inhibitors |
| 06/26/2003 | US20030119856 Thiazole compounds useful as inhibitors of protein kinase |
| 06/26/2003 | US20030119854 Compounds and methods for modulating CXCR3 function |
| 06/26/2003 | US20030119843 Tricycloheteroaromic ring containing imidazole compounds used as farnesyl transferase and geranylgeranyl transferase inhibitor |
| 06/26/2003 | US20030119839 Indalones and other fused heterocylce-ones |
| 06/26/2003 | US20030119836 Cyclooxygenase inhibitors |
| 06/26/2003 | US20030119835 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 06/26/2003 | US20030119834 Angiogenesis inhibitors; 3-alkyl-4-one quinazoline derivatives |
| 06/26/2003 | US20030119829 4-amino-5,6-substituted thiopheno [2,3-d] pyrimidines, pharmaceutical compositions containing the same, and their use in the treatment or prevention of PDE7B-mediated diseases and conditions |
| 06/26/2003 | US20030119827 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases |
| 06/26/2003 | US20030119820 Substituted indoles |
| 06/26/2003 | US20030119819 Anticancer agents |
| 06/26/2003 | US20030119816 Cycline-dependent kinase protein inhibitors; antiproliferative agents |
| 06/26/2003 | US20030119809 Methods and therapeutic combinations for the treatment of xanthoma using sterol absorption inhibitors |
| 06/26/2003 | US20030119800 Administering an ANGELS (Activators of Non-Genotropic Estrogen-like Signaling compound"ANGELS") compound to maintain or increase bone mass, bone density and/or bone strength. |
| 06/26/2003 | US20030119795 Vitamin D and its analogs in the treatment of tumors and other hyperproliferative disorders |
| 06/26/2003 | US20030119788 N-cyanomethyl carbonamides and sulfonamides which are cysteine protease, particularly cathepsin K, inhibitors |
| 06/26/2003 | US20030119780 Therapeutical treatments |
| 06/26/2003 | US20030119769 Antisense oligonucleotide modulation of raf gene expression |
| 06/26/2003 | US20030119749 Novel compounds possessing antibacterial, antifungal or antitumor activity |
| 06/26/2003 | US20030119746 Treatment of both primary and metastatic solid tumors |
| 06/26/2003 | US20030119744 Treatment with Prostate Secretory Protein-94 led to a near normalization of plasma calcium and a marked reduction in PTHrP production |
| 06/26/2003 | US20030119735 Delivery system |
| 06/26/2003 | US20030119726 P-glycoproteins and uses thereof |
| 06/26/2003 | US20030119715 Prevent retinoid binding; antiaging agents; activation cell differentiation |
| 06/26/2003 | US20030119187 Antigen presenting cells, method for their preparation and their use for cancer vaccines |
| 06/26/2003 | US20030119182 Immunotherapy; genetic engineering; anticancer agents |
| 06/26/2003 | US20030119168 Diagnosis of anticancer agents using nucleic acids |
| 06/26/2003 | US20030119148 Amino-terminally truncated rantes as chemokine antagonists |
| 06/26/2003 | US20030119111 G-protein coupled receptor, named 2871 receptor |
| 06/26/2003 | US20030119104 Genetic engineered artificial chromosomes in plants, animals |
| 06/26/2003 | US20030119095 Novel nucleic acid sequences encoding human vesicle transport protein-like and residue rat-like polypeptides |
| 06/26/2003 | US20030119078 Method of reducing immunogenicity of toxicity of an antibody of IgG class |
| 06/26/2003 | US20030119076 B7-like polynucleotides, polypeptides, and antibodies |
| 06/26/2003 | US20030119072 Methods for modulating signal transduction mediated by TGF-beta related proteins |
| 06/26/2003 | US20030119070 Complexing ligand, peptide ; displacement of one ligand with another |
| 06/26/2003 | US20030119045 Controlling cell proliferation; adjust adhesion to substrate |
| 06/26/2003 | US20030119036 Isolated nucleic acids; anticholesterol agents, cardiovascular disorders, antiinflammatory agents, antilipemic agents |
| 06/26/2003 | US20030118993 Nucleic acid which is upregulated in human tumor cells, a protein encoded thereby and a process for tumor diagnosis |
| 06/26/2003 | US20030118678 Plant extracts as antiproliferative, viricides and antiparasitic agents |
| 06/26/2003 | US20030118677 Method of isolating extract from the euphorbaciae obesa plant and methods for using the same |
| 06/26/2003 | US20030118661 Soft-shelled turtle, ageratum, ginseng and glucose; aging resistance |
| 06/26/2003 | US20030118657 Treatment of disease states characterized by excessive or inappropriate angiogenesis |
| 06/26/2003 | US20030118638 Oral pharmaceutical products containing 17 beta-estradiol-3-lower alkanoate, method of administering the same and process of preparation |
| 06/26/2003 | US20030118627 Glyceraldehyde 3 phosphate dehydrogenase enzyme inhibitors |
| 06/26/2003 | US20030118606 Contains mycelium fraction of a product obtained by incubation of mycelia of Ganoderma boninense and induces production of interleukin 12; use as terminal cancer treatment or supplementary food preparation |
| 06/26/2003 | US20030118600 Transfer compounds, production and use thereof |
| 06/26/2003 | US20030118588 Compound comprising an agonist anti-4-1BB antibody, or fragment thereof which stimulates the 4-1BB receptor; for treating tumors or infectious diseases |
| 06/26/2003 | US20030118570 Vectors for tissue-specific replication |
| 06/26/2003 | US20030118564 Intra-tumoral administration of il-12 encoding nucleic acid molecules |
| 06/26/2003 | US20030118553 Vector constructs for gene-therapy mediated radionuclide therapy of undifferentiated and medullary thyroid carcinomas and non-thyroidal tumours and metastases mediated thereof |
| 06/26/2003 | US20030118528 Topical delivery of codrugs |
| 06/26/2003 | US20030118507 Methods of using 46828, a human acyl-CoA synthetase |
| 06/26/2003 | CA2746308A1 Method for treating human papilloma virus |
| 06/26/2003 | CA2473938A1 Human adam-10 inhibitors |
| 06/26/2003 | CA2471777A1 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control |
| 06/26/2003 | CA2471589A1 Pharmaceutical conjugates with enhanced pharmacokinetic characteristics |
| 06/26/2003 | CA2470763A1 Novel pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases |
| 06/26/2003 | CA2470723A1 3,4-dihydro-1h-isoquinolin-2-yl-derivatives |
| 06/26/2003 | CA2470640A1 Use of hmgb proteins and nucleic acids that code therefor |
| 06/26/2003 | CA2470616A1 Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 06/26/2003 | CA2470322A1 Methods for particle-assisted polynucleotide immunization using a pulsed electric field |
| 06/26/2003 | CA2470311A1 Method of screening compounds |
| 06/26/2003 | CA2470307A1 Protein kinase inhibitors |
| 06/26/2003 | CA2470236A1 Lactams as tachykinin antagonists |
| 06/26/2003 | CA2470214A1 3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer |
| 06/26/2003 | CA2470060A1 Improvements in pharmaceutical compositions |
| 06/26/2003 | CA2469984A1 Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor |
| 06/26/2003 | CA2469976A1 Improvements in pharmaceutical compositions |
| 06/26/2003 | CA2469799A1 Use of a lysolipid for the preparation of a composition for transfection of a polynucleotide into a cell |
| 06/26/2003 | CA2469205A1 Bioadhesive drug delivery system with enhanced gastric retention |
| 06/26/2003 | CA2469048A1 Quinolinones as prostaglandin receptor ligands |